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It is nearly half a century since the classical genetic 
experiments of Barbara McClintock revealed to her the 
existence of transposing DNA elements in maize (see 
McClintock, 1992). The intervening years have witnessed 
the identification of an ever-increasing number of similar 
elements from the lowly bacterial insertion sequences to 
the complex genome of bacteriophage Mu and from the 
invaluable P element, tool of Drosophila genetics, to the 
medically devastating HIV retrovirus. Time has also seen 
dramatic growth in our level of knowledge and understand- 
ing of DNA transposition as the geneticists have given way 
first to the molecular biologists, then to the biochemists, 
and now to the X-ray crystallographers. In four recent pa- 
pers, the crystal structures of the catalytic domains of 
three transposase proteins have been reported, starting 
in December of last year with the HIV integrase and now 
with the Mu transposase and the avian sarcoma virus 
(ASV) integrase (Dyda et al., 1994; Rice and Mizuuchi, 
1995; Bujacz et al., 1995, 1996). 
The Process of Transposition 
Biochemical studies have shown that the enzymes of 
transposition, the transposases (including retroviral integ- 
rases), are responsible for the breaking and joining of DNA 
during the movement of transposable elements (Mizuuchi, 
1992; Katz and Skalka, 1994). In some, perhaps all, cases 
they are also responsible for bringing together the two 
element ends in a synaptic complex prior to catalysis of 
DNA cleavage. During transposition, a transposase per- 
forms two distinct and sequential reactions on its DNA 
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substrate (Figure 1). First, following recognition and bind- 
ing to the transposable element, the transposase acts as 
a site-specific endonuclease cleaving the DNA to expose 
the element’s 3’-OH ends. A subset of transposases (e.g., 
Tn7, TnlO) cleave both DNA strands, severing all connec- 
tions between transposon and flanking DNA; however, 
only the 3’-OH ends participate in the second phosphoryl 
transfer (see Mizuuchi, 1992). A duplex target DNA is then 
brought into the complex and, by direct attack of the 3’-OH 
ends of the element on the relevant phosphates, is cleaved 
and joined to the element’s ends in a single step. Since 
the phosphates attacked by the transposon ends are stag- 
gered (by 5 bp in the case of Mu and HIV and by 6 bp for 
ASV), the product contains a short single strand gap at 
each transposon-target junction; this is subsequently 
filled in, presumably by host repair functions. Strong evi- 
dence that the phosphoryl transfers involved in 3’ pro- 
cessing and strand transfer both occur by a single-step 
mechanism has been obtained for HIV integrase and Mu 
transposase using chiral thiophosphates at the cleaved 
position; each single reaction analyzed resulted in an in- 
version of the stereochemical configuration of the phos- 
phorothioate (Mizuuchi, 1992). Divalent cations are re- 
quired for both catalytic steps. However, although Mg*+ 
is expected to be the relevant cofactor in vivo, some of 
the transposases so far studied only show detectable ac- 
tivity in vitro in the presence of Mn*+. 
The chief similarities and differences between the reac- 
tions catalyzed by Mu transposase and the retroviral integ- 
rases are illustrated in Figure 1. The natural substrate for 
integrase, IN, is a linear duplex DNA copy of the viral RNA 
genome with just 2 bp beyond the ends of the transposing 
unit. In Mu transposition, by constrast, the transposon is 
embedded in long genomic sequences derived from its 
bacterial host and is supercoiled. In vivo, strand transfer 
Flgure 1. ReactIons Catalyzed by the Retrovi- 
ral lntegrases and Mu Transposase 
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must be a coupled, two-ended reaction (since both ends 
of an element insert into the same target site), indicating 
that it occurs within a synaptic complex. For Mu, assembly 
of this synaptic complex, consisting of a tetramer of trans- 
posase, MuA, at the paired ends of Mu, is a prerequisite 
not only of strand transfer, but also of end cleavage in 
vitro (Mizuuchi et al., 1992). Synapsis of two ends appears 
to be important also for 3’-end processing by retroviral 
integrases (Murphy and Goff, 1992; Kokolj and Skalka, 
1995), even though both cleavage and strand transfer 
steps occur in vitro as uncoupled reactions with single- 
ended substrates, producing single-end insertion products. 
A Transposase Superfamily 
The Mu transposase and the retroviral integrases are, at 
first sight, very different enzymes. The Mu transposase is 
a 663 residue (75 kDa) protein divisible into several func- 
tional domains, the largest of which (327 residues) con- 
tains the active site (although recent reports suggest con- 
tributions from another domain [Wu and Chaconas, 1995; 
Yang et al., 19951) and binds nonspecifically to DNA (see 
Mizuuchi, 1992). Other domains are responsible for bind- 
ing specifically to the ends of the transposon, for binding 
to an enhancer-like sequence, and for interaction with the 
Mu6 protein (an activator of transposition). The HIV and 
ASV integrases are less than half the size of MuA (about 
290 residues) and contain three domains: an N-terminal 
domain of uncertain function but with a His2-Cys2 zinc- 
binding motif, a central catalytic domain (about 160 resi- 
dues), and a C-terminal domain with DNA-binding activity 
(see Katz and Skalka, 1994). 
Despite their many obvious differences, which probably 
reflect the differences in lifestyle of each virus, MuA and 
the retroviral integrases may be related. Extensive and 
careful sequence comparisons over the last few years 
have indicated that the integrases are related to many 
transposases; sequence similarities are confined chiefly 
to the catalytic domain, and, although quite extensive in 
some cases (e.g., between the integrases and the IS3 
family of transposases), in others they are barely detect- 
able (Fayet et al., 1990; Kulkosky et al., 1992; Doak et al., 
1994). Interestingly, Mu transposase was not included in 
this superfamily of proteins until very recently, and even 
then the preferred sequence alignments (Baker and Luo, 
1994; Kim et al., 1995) have been shown by structural 
comparisons to be only partially correct (see below). The 
most notable feature of these conserved segments is a 
triad of “invariant” carboxylate residues, two aspartates 
and a glutamate known as the DDE motif. These three 
conserved residues are well separated in the primary se- 
quence with spacers of about 50-70 residues between 
the two aspartates and 35 residues (often, but not always) 
between the second aspartate and the glutamate. Even 
conservative substitutions at these positions have a dras- 
tic effect on cleavage and strand transfer (Kulkosky et 
al., 1992; Baker and Luo, 1994; Kim et al., 1995). The 
presence of these conserved carboxylates, their essential 
nature and the requirement for divalent metal ion during 
catalysis led to the suggestion that these enzymes may 
promote phosphoryl transfers by a process similar to the 
two-metal ion mechanism proposed for the 3-5’ exo- 
nuclease of DNA polymerase I (see Joyce and Steitz, 
1994). 
Three Transposase Crystal Structures 
The X-ray crystal structures of the catalytic core domain 
of three members of the transposasenntegrase family (Fig- 
ure 2) have both confirmed some predictions and provided 
some surprises. As has so often been the case in structural 
biology, additional information came to light with each 
structure, a strong argument for independent efforts on 
related problems. 
HIV lntegrase 
The portion crystallized by Dydaet al. (1994) was the cata- 
lytic core domain, residues 50-212. Although this domain 
fails to catalyze end-processing or integration, it does per- 
form a phosphoryl transfer, releasing the viral end from 
the branched strand transfer product (a reaction called 
disintegration); thus, the core domain contains an intact 
catalytic site. The insolubility of the HIV-1 integrase (in- 
deed, of transposases in general) and of the integrase core 
domain alone appeared to be an almost insurmountable 
barrier to crystallographic studies. In an effort, clearly suc- 
cessful, to overcome this problem, Craigie and colleagues 
performed a mutagenic tour-de-force by systemically re- 
placing all hydrophobic residues in the core domain of the 
integrase. Much improved solubility was obtained with the 
single substitution of lysine for Phe-165. This mutant re- 
tained disintegration activity. Crystals of this mutant do- 
main were grown in the absence of either DNA substrate 
or divalent cations. 
The structure alone, a mixed a6 structure with a central 
6 sheet, was perhaps a little disappointing, since only the 
two aspartate residues (Asp-64 and Asp-l 16) of the DDE 
triad were visible. These two were close to one another, 
however, and the third carboxylate, Glu-152, located on 
a 13 residue disordered region, seemed likely to be located 
in the same general area, compatible with the proposed 
role of the three carboxylates in metal binding and cataly- 
sis. A remarkable feature of the structure was its striking 
and unexpected similarity to three other proteins involved 
in phosphoryl transfers: RNase H (both of Escherichia coli 
and the RNase H domain of HIV reverse transcriptase) 
and RuvC, the enzyme that resolves Holliday junctions 
(Katayanagi et al., 1990; Yang et al., 1990; Davies et al., 
1991; Ariyoshi et al., 1994). Moreover, the two invariant 
aspartate residues of integrase superimposed on two cata- 
lytically essential aspartates of RNase H that participate 
in metal ion binding (Davies et al., 1991; for a discussion 
of the structural similarities, see Yang and Steitz, 1995a). 
The obvious conclusion is that all these enzymes use a 
common catalytic mechanism. 
One additional interesting feature of the HIV integrase 
structure was a substantial interface between monomers 
related by a crystallographic twofold axis. Dyda et al. 
(1994) suggest that the large distance between the two 
active sites (about 35 A) makes this dimer unsuitable for 
the concerted strand transfer reaction at the two ends 
(which occur just 5 bp apart [ - 17 A in B-DNA] at the target 
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Figure 2. Structures of the Catalytic Domains of Mu Transposase, HIV-1 Integrase, and ASV lntegrase 
site) but would be compatible with a model involving a 
tetramer of integrase, with one dimer bound at each end. 
We note, however, that a comparable situation exists for 
another recombinase: the dimer of y6 resolvase, which is 
demonstrably responsible for the coupled cleavages (sep- 
arated by only 2 bp or about 13 A) at a single crossover 
site (Boocock et al., 1995) has widely separated active 
sites (>30 A) even in the cocrystal structure with its DNA 
substrate that was solved recently by Yang and Steitz 
(1995b). 
Mu Transposase 
As with the integrases, the crystallized portion determined 
by Rice and Mizuuchi (1995) was the core catalytic do- 
main. However, in the case of Mu transposase, this do- 
main, residues 248-574, was about twice the size of its 
integrase counterpart. Several features distinguished the 
Mu structure. First, it consisted of two subdomains-a 233 
residue N-terminal a8 structure with striking structural ho- 
mology, yet weak sequence similarity, to the integrase 
domain, and a C-terminal 70 residue 8 barrel. Electrostatic 
calculations indicated a large region of positive potential 
on one surface of the 8 barrel, and Rice and Mizuuchi 
argue that it is responsibleforthe nonspecific DNA-binding 
activity of the entire core domain. 
The second feature of the Mu transposase structure was 
that all three carboxylates of the conserved DDE triad were 
visible. Perhaps because divalent metal ions were omitted 
or because the isolated domain shows no catalytic activity 
(indeed, the intact transposase is only active in its DNA- 
dependent tetrameric configuration), the carboxyl groups 
were not suitably positioned for binding a metal ion cooper- 
atively. The conserved glutamate (invisible in HIV integ- 
rase) was on a loop with its side chain pointing out into 
solvent. Noting that in other homologous structures (HIV 
integrase and RNase H) this loop is often disordered, Rice 
and Mizuuchi propose that a simple rearrangement could 
bring the glutamate into the aspartate-containing active 
site region; a picture of such a conformational adjustment 
is provided, perhaps, by the ASV integrase structure dis- 
cussed below. An important byproduct of the combined 
structures of Mu transposase and HIV integrase is that 
they allow a revised, structure-based alignment of the pri- 
mary amino acid sequences of the two proteins. Just 22 
of the 220 Mu residues (180 HIV residues) over the struc- 
turally homologous a8 domain are identical between the 
two proteins (and this number drops by half in a three-way 
comparison with ASV). The alignment confirms the identi- 
ties of Asp-269 and Glu-392 and positively identifies Asp- 
336 as the three members of the Mu DDE motif. 
In crystals of the Mu transposase, two regions of the 
surface appeared to play a role in forming interactions 
between monomers. However, the details of the interac- 
tions varied from one crystal form to another, putting their 
biological relevance intoquestion. Interestingly, aC-terminal 
a helix of the catalytic subdomain prevented formation of 
the dimer interface observed with HIV integrase. 
ASV lntegrase 
Not surprisingly, considering their sequence similarity, the 
structure of the catalytic domain of ASV integrase (residues 
52-207) was very similar to that of the HIV enzyme (al- 
though the residues forming the C-terminal a helix of the 
HIV structure were missing from the ASV domain) (Bujacz 
et al., 1995). Moreover, the ASV domain crystallized in 
the same dimeric configuration. In addition to its high reso- 
lution, the ASV integrase structure provided an example 
of a metal ion bound at the active site (Bujacz et al., 1996). 
Three structures were solved: a metal-free one and two 
containing either Mg2+ or Mn’+. Even in the absence of 
metal ions, the segment containing the invariant glutamate 
(disordered in HIV integrase and forming a loop inappropri- 
Cell 
1066 
ately positioned for catalysis in Mu transposase) was well 
ordered, forming the beginning portion of a long a helix, 
and the glutamate side chain was directed into the active 
site. There was an extensive network of hydrogen bonds 
that interconnected the three carboxyl groups via several 
ordered water molecules. One water interacted with the 
carboxyl groups of Asp-64 and Glu-157; another was coor- 
dinated by Asp-64 and Asp-121. When crystals were 
soaked in magnesium or manganese, a single metal ion 
could be seen, replacing the water coordinated by the two 
aspartates. Metal ion binding was accompanied by only 
modest changes in carboxylate positions, by far the largest 
(>l A) involving the unliganded glutamate. The presence 
of only one metal ion could be interpreted as supporting 
catalysis by a single metal ion, with the third unliganded 
carboxylate acting as a general base to activate the at- 
tacking water (or 3’-OH). However, an open question at 
this point is whether a second metal-binding site is formed 
in the presence of the additional negatively charged phos- 
phates that constitute the substrate. The presence of two 
metal ions in the active site of HIV RNase H with the appro- 
priate 4 A separation (Davies et al., 1991) inclines us to 
the view that this class of enzymes will use the two-metal 
ion mechanism; no doubt time will tell. 
These structures of transposase catalytic domains are 
an important and exciting step toward obtaining a more 
complete understanding of transposase function. How- 
ever, many years ago, Jeremy Knowles (see Gutfreund 
and Knowles, 1967) while acknowledging that a protein 
structure is essential for understanding its enzymatic 
mechanism, observed that a model of a horse does not 
necessarily tell us how fast it can run. He might have added 
that a picture of just part of a horse with no view of the 
ground might leave some ambiguity in how the horse even 
stands up. The structures obtained are a tribute to the 
persistence and effort of the scientists involved. In the 
kinetic pathway of understanding mechanism, they put us 
over the first energy barrier; maybe the rate-limiting step 
has even been accomplished. Clearly, the next major mile- 
stone of a structural nature will be a picture of an intact 
transposase with metal ion(s) and bound DNA substrate. 
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